Study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination
A study involving Professor Peter Johnson from the Centre for Cancer Immunology, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.
A study involving Professor Peter Johnson from the Centre for Cancer Immunology, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.
The researchers say that the study highlights the importance of COVID-19 vaccination boosters for cancer patients.
The UK Coronavirus Cancer Evaluation Project is the world’s largest analysis of the effect of COVID-19 vaccination on people with cancer and is published in The Lancet Oncology.
Related Staff Member
Professor Peter Johnson CBE MD FRCP FMedSci
Professor Peter Johnson is Professor of Medical Oncology within Medicine at the University of Southampton.
Read more